Petronela Ancuta

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Dietary intervention through bacterial-derived butyrate elicits anti-tumor activity and increases anti-PD-1 response.

Dietary intervention through bacterial-derived butyrate elicits anti-tumor activity and increases anti-PD-1 response.

Journal: Gut microbes

Published: July 15, 2026

Tumor Biomarkers in Head and Neck Squamous Cell Carcinoma: From Etiology and Pathogenesis to Treatment Response-A Scoping Review.

Tumor Biomarkers in Head and Neck Squamous Cell Carcinoma: From Etiology and Pathogenesis to Treatment Response-A Scoping Review.

Journal: Biomedicines

Published: July 11, 2026

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Journal: Research square

Published: June 12, 2026

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription.

Journal: Research square

Published: June 12, 2026

Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription.

Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

Plasma GDF-15 Levels Are Associated With HIV Reservoir Markers Independently of Inflammation in People With HIV on Antiretroviral Therapy.

Plasma GDF-15 Levels Are Associated With HIV Reservoir Markers Independently of Inflammation in People With HIV on Antiretroviral Therapy.

Journal: The Journal of infectious diseases

Published: January 23, 2026

HCV-specific CD4+ T-cells are susceptible to HIV-1 and contribute to viral persistence during antiretroviral therapy.

HCV-specific CD4+ T-cells are susceptible to HIV-1 and contribute to viral persistence during antiretroviral therapy.

Journal: EBioMedicine

Published: January 20, 2026

Pharmacological and genetic modulation of IL-32 expression in intestinal epithelial cells does not impact HIV-1 outgrowth in co-cultured CD4+ T-cells.

Pharmacological and genetic modulation of IL-32 expression in intestinal epithelial cells does not impact HIV-1 outgrowth in co-cultured CD4+ T-cells.

Journal: Frontiers in immunology

Published: December 16, 2025

Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.

Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.

Journal: Immunity & ageing : I & A

Published: October 07, 2025

Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.

Gut-heart immuno-metabolic disruption associated with inflammaging and subclinical coronary artery disease in people with HIV on antiretroviral therapy.

Journal: Immunity & ageing : I & A

Published: October 07, 2025

Alterations in Circulating T-Cell Subsets with Gut-Homing/Residency Phenotypes Associated with HIV-1 Status and Subclinical Atherosclerosis.

Alterations in Circulating T-Cell Subsets with Gut-Homing/Residency Phenotypes Associated with HIV-1 Status and Subclinical Atherosclerosis.

Journal: Cells

Published: September 23, 2025

Reflections upon a life well-lived: A tribute to Ron Rosenes.

Reflections upon a life well-lived: A tribute to Ron Rosenes.

Journal: Journal of virus eradication

Published: May 09, 2025

Showing 1-12 of 91

Last Updated: 09/26/2026